Clorox (NYSE:CLX) Price Target Cut to $130.00

Clorox (NYSE:CLX) had its price objective decreased by equities research analysts at Wells Fargo & Company from $135.00 to $130.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has an “underweight” rating on the stock. Wells Fargo & Company‘s price objective indicates a potential downside of 1.90% from the stock’s current price.

A number of other equities research analysts also recently issued reports on the stock. Evercore ISI reduced their price target on shares of Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. Argus upgraded shares of Clorox to a “hold” rating in a research report on Tuesday, June 4th. Morgan Stanley reiterated an “equal weight” rating and set a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. DA Davidson reiterated a “neutral” rating and set a $162.00 price target on shares of Clorox in a research report on Wednesday, April 17th. Finally, Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a research report on Wednesday, April 17th. Five analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $145.00.

Clorox Stock Performance

CLX traded up $0.67 during trading on Wednesday, reaching $132.52. The company’s stock had a trading volume of 180,403 shares, compared to its average volume of 1,242,190. Clorox has a 52-week low of $114.68 and a 52-week high of $169.14. The company’s fifty day moving average price is $134.97 and its 200-day moving average price is $143.35. The company has a market capitalization of $16.46 billion, a price-to-earnings ratio of 68.52, a price-to-earnings-growth ratio of 1.97 and a beta of 0.39. The company has a debt-to-equity ratio of 9.73, a quick ratio of 0.53 and a current ratio of 0.90.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The company had revenue of $1.81 billion for the quarter, compared to analyst estimates of $1.87 billion. During the same quarter in the previous year, the company earned $1.51 EPS. The firm’s revenue for the quarter was down 5.3% compared to the same quarter last year. On average, equities analysts forecast that Clorox will post 5.91 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Venturi Wealth Management LLC raised its holdings in Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock valued at $29,000 after acquiring an additional 145 shares during the last quarter. Northwest Financial Advisors acquired a new position in Clorox in the 4th quarter valued at $29,000. GoalVest Advisory LLC acquired a new position in Clorox in the 1st quarter valued at $31,000. First Foundation Advisors acquired a new position in Clorox in the 1st quarter valued at $31,000. Finally, Core Wealth Advisors Inc. acquired a new position in Clorox in the 4th quarter valued at $29,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.